This article is freely available to all

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We report a case of Stevens-Johnson syndrome (SJS) believed to be induced by venlafaxine in a woman with major depressive disorder who showed improvement in her rash when venlafaxine was discontinued. This report emphasizes that prescribers must aggressively follow up patients who have rashes while on treatment with any antidepressant, discontinuing the medication as soon as a serious skin reaction is suspected and watching closely for the emergence of potentially life-threatening dermatologic conditions.